Last reviewed · How we verify

NCT03102905: REPLIPO

Prevalence of Replication of Human Herpes Virus 6 (HHV6) in Blood and Skin During Exanthemia, in Patients With Hemopathy. Is There a Correlation With the Etiology of the Exanthema?

Status unknown Last updated 6 April 2017
What this trial tests

trial testing Measurement of the prevalence of the positivity of cutaneous HHV6 quantitative PCR in the cohort studied. in HHV6 in 45 participants. Status unknown.

Timeline
13 December 2016
Primary endpoint
13 June 2017
13 June 2017

Quick facts

Lead sponsorCentre Hospitalier Universitaire, Amiens
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment45
Start date13 December 2016
Primary completion13 June 2017
Estimated completion13 June 2017
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire, Amiens

Who can join

Eligibility, any sex, with HHV6 or Exanthema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To look for the replication of HHV6 by PCR in the skin, in these patients with haemopathies presenting an exanthema. This will make it possible to evaluate the prevalence of the positivity of this PCR in the skin. Then the investigator can investigate whether there is an association between the positivity of HHV6 PCR in the blood and / or skin and the viral etiology of the exanthema. If this association exists, it will make it possible to improve the diagnosis in the context of the exanthema and thus to improve the therapeutic management of these patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Centre Hospitalier Universitaire, Amiens trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03102905.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing